Ivuxolimab

CAT: 0931-T78275-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0931-T78275-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
2128729-41-7
Target
Interleukin|||TNF
Related Pathways
Apoptosis|||Immunology/Inflammation
Purity
0.967
Bioactivity
Ivuxolimab is a fully human immunoglobulin G2 (IgG2) monoclonal antibody functioning as an agonist that targets the OX40 receptor (CD134), which selectively binds to the OX40 receptor expressed on the surface of activated CD4+ and CD8+ T cells without inducing antibody-dependent cellular cytotoxicity. Ivuxolimab can promote T cell proliferation, enhance cell survival, stimulate cytokine secretion (such as IFN-? and IL-2), inhibit the suppressive function of regulatory T cells (Tregs), and potentiate anti-tumor immune responses, enabling its use in the study of cancers including melanoma, hepatocellular carcinoma, and head and neck squamous cell carcinoma.
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName

Alternative Products

CatalogName
MBS5819942Ivuxolimab
DHE43201Research Grade Ivuxolimab
KET-10738Ivuxolimab ELISA Kit
E55B0383Ivuxolimab (Reference antibody)
ICH5119-50mgIvuxolimab Biosimilar - Research Grade
A137746Ivuxolimab Biosimilar (Monoclonal, IgG2)
ABS-287-1mgIvuxolimab Biosimilar, Research Grade

Popular Products